Spindle Cell Rhabdomyosarcoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

Aliases & Classifications for Spindle Cell Rhabdomyosarcoma

Sources:
¹¹Disease Ontology, ¹³DISEASES, ⁴⁵NCIt, ⁶²SNOMED-CT, ⁶⁸UMLS
See all MalaCards sources

Aliases & Descriptions for Spindle Cell Rhabdomyosarcoma:

Name: Spindle Cell Rhabdomyosarcoma ¹¹ ¹³ ⁶⁸

Classifications:

MalaCards categories:
Global: Cancer diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology¹¹ DOID:3260

SNOMED-CT⁶² 128749008, 404055006

NCIt⁴⁵ C6519

UMLS⁶⁸ C1266134

Summaries for Spindle Cell Rhabdomyosarcoma

Sources:
³⁶MalaCards, ⁷¹Wikipedia
See all MalaCards sources

Wikipedia:⁷¹ Spindle cell rhabdomyosarcoma is a subtype of embryonal rhabdomyosarcoma first described by Cavazzana,... more...

MalaCards based summary: Spindle Cell Rhabdomyosarcoma is related to embryonal rhabdomyosarcoma and rhabdomyosarcoma. An important gene associated with Spindle Cell Rhabdomyosarcoma is MYOD1 (Myogenic Differentiation 1), and among its related pathways are Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers and Neural Stem Cell Differentiation Pathways and Lineage-specific Markers. Affiliated tissues include tongue and prostate, and related mouse phenotype muscle.

Related Diseases for Spindle Cell Rhabdomyosarcoma

Sources:
²⁰GeneAnalytics, ²¹GeneCards
See all MalaCards sources

Diseases related to Spindle Cell Rhabdomyosarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 124)

id	Related Disease	Score	Top Affiliating Genes
1	embryonal rhabdomyosarcoma	11.4
2	rhabdomyosarcoma	10.5
3	ectopic pregnancy	10.2	DES, MYOD1
4	testis sarcoma	10.2	DES, MYOD1
5	cardiac tamponade	10.2	DES, MYOD1
6	extraosseous osteosarcoma	10.2	DES, MYOD1
7	glaucoma iridogoniodysgenesia	10.2	DES, MB
8	reticulohistiocytic granuloma	10.2	DES, MB
9	foix-alajouanine syndrome	10.2	DES, S100B
10	extracutaneous mastocytoma	10.2	DES, MB
11	cavernous sinus meningioma	10.2	DES, S100B
12	dyslexia	10.2	DES, S100B
13	rectal neoplasm	10.2	DES, MB
14	t-cell childhood lymphoblastic lymphoma	10.2	DES, MB
15	brain stem infarction	10.2	MB, MYOD1
16	invasive malignant thymoma	10.2	DES, MUC1
17	marfanoid hypermobility syndrome	10.2	DES, MUC1
18	tanycytic ependymoma	10.1	DES, MUC1
19	endodermal sinus tumor	10.1	MB, MYOD1
20	glomerulonephritis	10.1	MB, MYOD1
21	petrous apex meningioma	10.1	DES, MUC1
22	episodic ataxia	10.1	DES, MUC1
23	polydactyly cleft lip palate psychomotor retardation	10.1	DES, MUC1
24	coronary stenosis	10.1	DES, MUC1
25	van regemorter pierquin vamos syndrome	10.1	DES, MB
26	sebaceous adenoma	10.1	DES, MUC1
27	anal gland neoplasm	10.1	DES, MUC1
28	pseudohermaphrodism anorectal anomalies	10.1	DES, MUC1
29	omodysplasia 2	10.1	DES, MUC1
30	congenital muscular dystrophy with hyperlaxity	10.1	DES, MUC1
31	hyperpituitarism	10.1	DES, MB
32	lucey-driscoll syndrome	10.1	MUC1, S100B
33	secondary pulmonary hemosiderosis	10.1	MUC1, S100B
34	invasive mole	10.1	MUC1, S100B
35	pemphigus vegetans	10.1	MUC1, S100B
36	postgerminal center chronic lymphocytic leukemia/small lymphocytic lymphoma	10.1	MUC1, S100B
37	corneal intraepithelial neoplasm	10.1	MUC1, S100B
38	orthostatic proteinuria	10.1	DES, MUC1
39	subglottis verrucous carcinoma	10.1	MUC1, S100B
40	conjunctival cancer	10.1	MUC1, S100B
41	clear cell ependymoma	10.1	MUC1, S100B
42	endocardium cancer	10.1	MUC1, S100B
43	precursor t-lymphoblastic lymphoma/leukemia	10.1	MUC1, S100B
44	kidney sarcoma	10.1	MYOD1, S100B
45	scirrhous adenocarcinoma	10.1	DES, MUC1
46	glucosidase acid-1,4-alpha deficiency	10.1	DES, GFAP
47	pulmonary neuroendocrine tumor	10.1	MUC1, S100B
48	uterine corpus leiomyomatosis	10.1	MUC1, S100B
49	gastrointestinal system cancer	10.1	MUC1, S100B
50	neutrophil immunodeficiency syndrome	10.1	DES, S100B

Graphical network of the top 20 diseases related to Spindle Cell Rhabdomyosarcoma:

Symptoms & Phenotypes for Spindle Cell Rhabdomyosarcoma

Sources:
⁴¹MGI
See all MalaCards sources

MGI Mouse Phenotypes related to Spindle Cell Rhabdomyosarcoma according to GeneCards Suite gene sharing:

⁴¹

id	Description	MGI Source Accession	Score	Top Affiliating Genes
1	muscle	MP:0005369	8.3	DES, GFAP, MB, MYOD1

Drugs & Therapeutics for Spindle Cell Rhabdomyosarcoma

Sources:
¹BitterDB, ⁴ClinicalTrials, ¹⁰DGIdb, ¹⁴DrugBank, ²⁹HMDB, ³³IUPHAR, ⁵⁰Novoseek, ⁵⁶PharmGKB
See all MalaCards sources

Drugs for Spindle Cell Rhabdomyosarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 27)

id

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

1

Everolimus

approved

Phase 3, Phase 1, Phase 2

1940

159351-69-6

6442177

Synonyms:

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-Dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.04,9)hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentaone

(1R,9S,12S,15R,16E,23S,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo(30.3.1.0(sup 4,9))hexatriacont

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-Hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-23,27-epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-3-{(2R)-1-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]propan-2-yl}-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34as)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34,34a-hexadecahydro-9,27-dihydroxy-3-((1R)-2-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-1-methylethyl)-10,21-dimethoxy-6,8,12,14,20,26-hexamethy

07741_FLUKA

159351-69-6

40-O-(2-hydroxyethyl)-rapamycin

42-O-(2-Hydroxyethyl)rapamycin

Afinitor

CERTICAN(R)

CHEMBL1201755

Certican

D02714

DB01590

Everolimus

Everolimus (JAN/USAN/INN)

Everolimus [USAN]

LS-143292

MolPort-003-847-342

MolPort-003-925-588

NCGC00167512-01

NVP-RAD-001

RAD 001

RAD-001

RAD-001C

RAD001

RAD001, SDZ-RAD, Certican, Zortress, Afinitor, Everolimus

S1120_Selleck

SDZ-RAD

UNII-9HW64Q8G6G

Zortress

everolimus

2

Sirolimus

approved, investigational

Phase 3, Phase 1, Phase 2

1940

53123-88-9

5284616, 6436030, 46835353

Synonyms:

(-)-Rapamycin

(-)-rapamycin

1fkb

1pbk

23,27-Epoxy-3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine

23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine

23,27-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29

3H-pyrido(2,1-c)(1,4)oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

53123-88-9

A422989, NSC226080

AC-722

AC1L1JH9

AC1L7MJ9

AC1L9ZMV

AY 22989

AY-22989

AY22989

Ambotz53123-88-9

Antibiotic AY 22989

BIDD:PXR0165

Bio1_000293

Bio1_000782

Bio1_001271

Bio2_000375

Bio2_000855

BiomolKI2_000084

C07909

C51H79NO13

CBiol_002007

CCRIS 9024

CHEBI:100923

CHEBI:9168

CHEMBL413

CID10213190

CID10795871

CID11949238

CID11959112

CID313006

CID478951

CID5040

CID5284616

CID5358081

CID5374464

CID5460439

CID5497196

CID5924240

CID6436030

CID6610270

CID6610346

CID6711160

CID6713081

CID9833581

CID9854379

CID9854380

CID9962926

CID9962928

D00753

DB00877

DE-109

DivK1c_006936

FT-0082351

HMS2089A21

HSDB 7284

KBio1_001880

KBio2_000410

KBio2_002978

KBio2_005546

KBio3_000779

KBio3_000780

KBioGR_000410

KBioSS_000410

LCP-Siro

LMPK06000003

LS-143290

MLS000028373

MS-R001

MolMap_000043

MolPort-003-959-433

NCGC00021305-05

NCI60_001851

NCIMech_000355

NSC 226080

NSC226080

Perceiva

QTL1_000069

R0395_SIAL

R0395_SIGMA

RAP

RAPA

RPM

Rapammune

Rapamune

Rapamune (TN)

Rapamycin

Rapamycin (TN)

Rapamycin C-7, analog 4

Rapamycin Immunosuppressant Drug

Rapamycin from Streptomyces hygroscopicus

S1039_Selleck

SIIA 9268A

SILA 9268A

SILA9268A

SMP1_000255

SMR000058564

Sirolimus

Sirolimus (RAPAMUNE)

Sirolimus (USAN/INN)

Sirolimus [USAN:BAN:INN]

Sirolimus, Rapamune,Rapamycin

SpecPlus_000840

UNII-W36ZG6FT64

UNM-0000358684

WY-090217

Wy 090217

heptadecahydro-9,27-dihydroxy-3-[(1R)-2-[(1S,3R,4R)-4-hydroxy

nchembio.100-comp4

nchembio.2007.42-comp2

nchembio.79-comp1

nchembio762-comp1

nchembio883-comp3

rapamycin

sirolimus

3

Miconazole

approved, investigational, vet_approved

Phase 3, Phase 1, Phase 2

3706

22916-47-8

4189

Synonyms:

(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole

1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole

1-[2,4-Dichloro- beta-([2,4-dichloro- benzyl]oxy)phenethyl]imidazole

1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole

1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole

1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole

1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole

1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole

1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole

22832-87-7 (NITRATE)

22916-47-8

75319-47-0

AB00053500

AC1L1HM1

AKOS001574474

Aflorix(nitrate)

Albistat(nitrate)

Andergin(nitrate)

BPBio1_000279

BRD-A82396632-001-03-0

BRD-A82396632-008-02-7

BRN 0965511

BSPBio_000253

BSPBio_002033

CCRIS 7924

CHEBI:6923

CHEMBL91

CID4189

CPD-4501

Conofite(nitrate)

D00416

DB01110

Dactarin

Daktarin IV

Daktarin iv

DivK1c_000156

EINECS 245-324-5

Epi-Monistat(nitrate)

Femizol-M

Florid(nitrate)

Gyno-Daktar(nitrate)

HMS1568M15

HMS2090B21

I14-14342

IDI1_000156

Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)

KBio1_000156

KBio2_001445

KBio2_004013

KBio2_006581

KBio3_001533

KBioGR_000581

KBioSS_001445

LS-78378

Lotrimin AF(nitrate)

MCZ

MJR 1762

MLS002222203

Micantin (nitrate)

Miconasil Nitrate

Miconazol

Miconazol [INN-Spanish]

Miconazole

Miconazole (JP15/USP/INN)

Miconazole 3

Miconazole 3 Combination Pack

Miconazole 7 Combination Pack

Miconazole [USAN:BAN:INN:JAN]

Miconazole nitrate salt

Miconazole-7

Miconazolo

Miconazolo [DCIT]

Miconazolum

Miconazolum [INN-Latin]

Micozole

Minostate

MolPort-002-557-553

Monazole 7

Monista (nitrate)

Monistat

Monistat (TN)

Monistat 1 Combination Pack

Monistat 3 Dual-Pak

Monistat 3 Vaginal Ovules

Monistat 5 Tampon

Monistat 7 Dual-Pak

Monistat 7 Vaginal Suppositories

Monistat Dual- PAK

Monistat IV

Monistat iv (TN)

Monistat iv (tn)

Monistat-Derm

NCI60_001353

NCI60_001380

NINDS_000156

NSC 170986

NSC169434

NSC170986

Novo-Miconazole Vaginal Ovules

Oprea1_091955

Prestwick0_000067

Prestwick1_000067

Prestwick2_000067

Prestwick3_000067

Prestwick_335

R 18134

R-14,889

SMR001307249

SPBio_000976

SPBio_002174

STK834405

STOCK1S-93556

Spectrum2_001048

Spectrum3_000507

Spectrum4_000061

Spectrum5_001297

Spectrum_000965

UNII-7NNO0D7S5M

Vusion

Zimycan

imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)

miconazole

4

Dactinomycin

approved

Phase 3

48

50-76-0

2019, 457193

Synonyms:

(- )-actinomycin d

(-)-actinomycin d

-pentone

01815_FLUKA

1H-Pyrrolo(2,1-1)-(1,4,7,10,13)oxatetraazacyclohexadecine

2-amino-N,N'-bis(hexadecahydro-2,5,9-trimethyl-6,13-bis(1-methylethyl)-1,4,7,11,14-pentaoxo-1H-pyrrolo(2,1-I)(1,4,7,10,13)oxatetra-azacyclohexadecin-10-yl)-4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

4,6-dimethyl-3-oxo-3H-phenoxazine-1,9-dicarboxamide

50-76-0

A1410_SIGMA

A4262_SIGMA

A9415_SIGMA

AC1L1CQX

AC1L9W52

ACT

ACT D

ACTINOMYCIN D

ACTINOMYCIN D AMP

ACTINOMYCIN-D

ACTO-D

ACon0_000471

ACon1_001004

AD

AD (VAN)

AI3-26374

ActD

Actactinomycin A IV

Actactinomycin a Iv

Actinomycin 11 Cosmegen

Actinomycin 11 cosmegen

Actinomycin 7

Actinomycin A IV

Actinomycin Aiv

Actinomycin C (sub1)

Actinomycin C(sub1)

Actinomycin C1

Actinomycin D

Actinomycin D (JP15)

Actinomycin D deriv. of 3H-phenoxaocardazine

Actinomycin D, sodium deoxyribonucleic acid complex

Actinomycin I

Actinomycin I (sub1)

Actinomycin I(sub 1)

Actinomycin I(sub1)

Actinomycin I1

Actinomycin IV

Actinomycin Iv

Actinomycin X 1

Actinomycin X1

Actinomycin iv

Actinomycin-(threo-val-pro-sar-meval)

Actinomycin-?IV

Actinomycin-[threo-val-pro-sar-meval]

Actinomycindioic D Acid, Dilactone

Actinomycindioic D acid, dilactone

Acto-D

Antibiotic From Streptomyces Parvullus

Antibiotic from Streptomyces parvullus

BCBcMAP01_000155

BRD-A42383464-001-02-2

Bio1_000342

Bio1_000831

Bio1_001320

C06770

C1

C62H86N12O16

CBiol_002056

CCRIS 9

CHEBI:123721

CHEBI:27666

CHEMBL1554

CHEMBL427947

CID2019

CID457193

COSMEGEN (TN)

CPD000469227

Chounghwamycin B

Cosmegen

D Actinomycin

D00214

DACTINOMYCIN

DB00970

DVA-DPR-SAR-MVA-(c1)DTH-PXZ-(c11)DTH-DVA-DPR-SAR-MVA

Dactinomicina

Dactinomicina [INN-Spanish]

Dactinomycin

Dactinomycin (USP)

Dactinomycin D

Dactinomycin [USAN:BAN]

Dactinomycine

Dactinomycine [INN-French]

Dactinomycinum

Dactinomycinum [INN-Latin]

Dilactone Actinomycin D Acid

Dilactone Actinomycindioic D Acid

Dilactone actin omycindioic D acid

Dilactone actinomycin D acid

Dilactone actinomycindioic D acid

EINECS 200-063-6

FT-0080366

GNF-PF-1977

HBF 386

HBF 386 Meractinomycin

HBF 386 meractinomycin

HMS2052O17

HSDB 3220

LMPK14000005

LS-142

Lyovac Cosmegen

Lyovac cosmegen

MEGxm0_000350

MLS001424196

Meractinomycin

MolPort-001-739-741

MolPort-003-925-177

NCGC00025059-02

NCGC00090796-01

NCGC00161622-01

NCGC00161622-02

NCGC00169767-01

NCI-C04682

NCI60_030539

NP-005932

NSC 3053

NSC-3053

NSC191297

NSC3053

Neuro_000003

Oncostatin K

Oxamide

PXZ-THR-DVA-PRO-SAR-MVA-THR-DVA-PRO-SAR-MVA

SAM001246846

SMP1_000005

SMR000469227

UNII-1CC1JFE158

UPCMLD-DP055

UPCMLD-DP055:001

UPCMLD-DP055:002

WLN: 16- AN FVN IVN LVO PVM SVTJ G1 J1 KY1&1 N1 RY1&1

X 97

actd

actinomycin D

actinomycin cl

actinomycin x i

actinomyein-theo-val-pro-sar-meval

dactinomyein d

o)-(1-oxo-1,2-ethanediyl)]bis(N-methyl)L-valine

5

Vincristine

approved, investigational

Phase 3

922

2068-78-2, 57-22-7

5978

Synonyms:

22-Oxovincaleukoblastin

22-Oxovincaleukoblastine

28379-27-3

57-22-7

AC1L1LJC

C07204

C46H56N4O10

CCRIS 5763

CHEBI:28445

CID5978

D08679

DB00541

EINECS 200-318-1

HMS2090E19

HSDB 3199

Indole alkaloid

LCR

LS-228

Leurocristine

Lilly 37231 (1:1 sulfate salt)

Liposomal Vincristine

Marqibo

NCGC00163700-01

NCI-C04864

NCI60_026703

NSC-67574

Onco TCS

Oncovin

Oncovin (1:1 sulfate salt)

Oncovine

Tecnocris

Tecnocris (TN)

UNII-5J49Q6B70F

VCR

VIN

Vincaleukoblastine, 22-oxo- 22-Oxovincaleukoblastine

Vincasar

Vincasar (1:1 sulfate salt)

Vincasar PFS

Vincrex

Vincrex (1:1 sulfate salt)

Vincristin

Vincristina

Vincristina [DCIT]

Vincristine (INN)

Vincristine Sulfate

Vincristine Sulfate PFS

Vincristine [INN:BAN]

Vincristinum

Vincristinum [INN-Latin]

Vincrstine

Vincrystine

Vinkristin

Z-D-Val-Lys(Z)-OH

vincristine

6

Cyclophosphamide

approved, investigational

Phase 3

2935

50-18-0, 6055-19-2

2907

Synonyms:

(+-)-Cyclophosphamide

(-)-Cyclophosphamide

(RS)-Cyclophosphamide

1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine

1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin

2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide

4-Hydroxy-cyclophosphan-mamophosphatide

50-18-0

60007-95-6

6055-19-2 (monohydrate)

75526-90-8

AC1L1EQQ

AI3-26198

ASTA

ASTA B518

Anhydrous cyclophosphamide

Asta B 518

B 518

B-518

BRN 0011744

BSPBio_002099

Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester

C 0768

C07888

C7H15Cl2N2O2P

CB 4564

CB-4564

CCRIS 188

CHEBI:4027

CHEMBL32520

CHEMBL88

CID2907

CP

CPA

CTX

CY

Ciclofosfamida

Ciclofosfamida [INN-Spanish]

Ciclofosfamide

Ciclophosphamide

Ciclophosphamide [INN]

Clafen

Claphene

Cycloblastin

Cyclophosphamid

Cyclophosphamide

Cyclophosphamide (INN)

Cyclophosphamide (TN)

Cyclophosphamide (anhydrous form)

Cyclophosphamide (anhydrous)

Cyclophosphamide Monohydrate

Cyclophosphamide Sterile

Cyclophosphamide anhydrous

Cyclophosphamide, (+-)-Isomer

Cyclophosphamides

Cyclophosphamidum

Cyclophosphamidum [INN-Latin]

Cyclophosphan

Cyclophosphane

Cyclophosphanum

Cyclophosphoramide

Cyclostin

Cyklofosfamid

Cyklofosfamid [Czech]

Cytophosphan

Cytophosphane

Cytoxan

Cytoxan (TN)

Cytoxan Lyoph

D,L-Cyclophosphamide

D07760

DB00531

DivK1c_000246

EINECS 200-015-4

EU-0100238

Endoxan

Endoxan R

Endoxan-Asta

Endoxana

Endoxanal

Endoxane

Enduxan

Genoxal

HMS2090A12

HSDB 3047

Hexadrin

IDI1_000246

KBio1_000246

KBio2_001338

KBio2_003906

KBio2_006474

KBio3_001319

KBioGR_000888

KBioSS_001338

LS-1302

LS-99787

Ledoxina

Lopac-C-0768

Lopac0_000238

Lyophilized Cytoxan

Mitoxan

MolPort-001-783-420

N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide

N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide

NCGC00015209-01

NCGC00015209-03

NCGC00015209-06

NCGC00091741-02

NCGC00091741-03

NCI-C04900

NCI60_002097

NINDS_000246

NSC 26271

NSC-26271

NSC26271

NSC273033

NSC273034

Neosar

Occupation, cyclophosphamide exposure

Procytox

RCRA waste no. U058

Rcra Waste Number U058

Rcra waste number U058

Revimmune

S1217_Selleck

SK 20501

SPBio_001071

STK177249

STOCK2S-91217

Semdoxan

Sendoxan

Senduxan

Spectrum2_001146

Spectrum3_000370

Spectrum4_000304

Spectrum5_000795

Spectrum_000858

UNII-6UXW23996M

WLN: T6MPOTJ BO BN2G2G

Zyklophosphamid

Zyklophosphamid [German]

bis(2-Chloroethyl)phosphami de cyclic propanolamide

bis(2-Chloroethyl)phosphamide cyclic propanolamide ester

cyclophosphamide

7

Irinotecan

approved, investigational

Phase 3

1123

97682-44-5, 100286-90-6

60838

Synonyms:

(+)-Irinotecan

(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE

(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate

1u65

97682-44-5

AC-7469

AC1L1U0Z

AC1Q6PGI

BRD-K08547377-003-02-4

BSPBio_002346

Bio-0054

Biotecan

Biotecan (TN)

C16641

C33H38N4O6

CHEBI:105985

CHEMBL481

CID60838

CP0

Campothecin-11

Campto

Camptosar

Camptosar, Campto, CPT-11, Irinotecan

Camptothecin-11

D08086

DB00762

FT-0083650

HSDB 7607

IRINOTECAN HYDROCHLORIDE Trihydrate

IRINOTECAN, CPT-11

Irinotecan (INN)

Irinotecan Hcl

Irinotecan Hydrochloride

Irinotecan Hydrochloride Trihydrate

Irinotecan [INN:BAN]

Irinotecan hydrochloride

Irinotecanum

Irinotecanum [INN-Latin]

LS-44589

NCI60_005051

NSC728073

S1198_Selleck

TL8006026

UNII-7673326042

irinotecan

8

Morphine

approved, investigational

Phase 3

1007

57-27-2

5288826

Synonyms:

(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(-)-Heroin hydrochloride

(-)-Morphine

(-)Morphine sulfate

(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol

(5R,6S,9R,13S,14R)-4,5-epoxy-N-methyl-7-morphinen-3,6-diol

(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5alpha,6alpha)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(5α,6α)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol

(5α,6α)-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL

(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano[1]benzofuro[3,2-e]isoquinoline-7,9-diol

(−)-morphine

17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol

4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol

4-methyl-(13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol

47106-99-0

57-27-2

6211-15-0 (sulfate (2:1) (salt) pentahydrate)

64-31-3

64-31-3 (sulfate (2:1) (salt) anhydrous)

7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol

7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol

8053-16-5

85201-37-2

Apokyn

Astramorph PF

Avinza

BIDD:GT0147

C01516

CCRIS 5762

CHEBI:17303

CHEMBL70

CID5288826

Cube juice

D-(-)-Morphine

DB00295

DEA No. 9300

DepoDur

Depodur

Diacetylmorphine hydrochloride

Diamorphine hydrochloride

Dolcontin

Dreamer

Dulcontin

Duramorph PF

Duromorph

EINECS 200-320-2

Epimorph

HSDB 2134

Hard stuff

Heroin hydrochloride

Heroine hydrochloride

Hocus

Infumorph

Kadian

LS-91748

M-Eslon

M.O.S

MOI

MORPHINE SULFATE

MORPHINE, (5A,6A)-7,8-DIDEHYDRO-4,5-EPOXY-17-METHYLMORPHINIAN-3,6-DIOL, MORPHIUM, MORPHIA, DOLCONTIN, DUROMORPH, MORPHINA, NEPENTHE

MS Contin

MS/L

MS/S

MSIR

Meconium

MolPort-003-849-273

Morfina

Morfina [Italian]

Morphia

Morphin

Morphin [German]

Morphina

Morphina [Italian]

Morphine Extra-Forte

Morphine Forte

Morphine H.P

Morphine Sulfate

Morphine [BAN]

Morphinism

Morphinum

Morphitec

Morphium

Morpho

Moscontin

Ms Contin

Ms Emma

NSC11441

Nepenthe

O,O'-Diacetylmorphine hydrochloride

OMS Concentrate

Oramorph SR

Ospalivina

RMS

RMS Uniserts

Rescudose

Roxanol

Roxanol 100

Roxanol UD

SDZ 202-250

SDZ202-250

Statex

Statex Drops

Statex SR

UNII-76I7G6D29C

Unkie

l-Morphine

morfina

morphine

nchembio.317-comp1

nchembio.64-comp1

9

Camptothecin

experimental

Phase 3

714

7689-03-4

Synonyms:

(+)-camptothecin

(+)-camptothecine

(s)-(+)-camptothecin

(s)-camptothecin

20(S)-Camptothecin

21,22-Secocamptothecin-21-oic acid lactone

Camptothecine

D-camptothecin

10

Topoisomerase Inhibitors

Phase 3, Phase 1, Phase 2

5069

11

Antifungal Agents

Phase 3, Phase 1, Phase 2

3696

12

Anti-Bacterial Agents

Phase 3, Phase 1, Phase 2

11226

13

Antibiotics, Antitubercular

Phase 3, Phase 1, Phase 2

7180

14

Anti-Infective Agents

Phase 3, Phase 1, Phase 2

22062

15

Immunosuppressive Agents

Phase 3, Phase 1, Phase 2

13086

16

Antimitotic Agents

Phase 3, Phase 1, Phase 2

5657

17

Antineoplastic Agents, Phytogenic

Phase 3, Phase 1, Phase 2

5602

18

Antirheumatic Agents

Phase 3

10956

19

Alkylating Agents

Phase 3

4827

20

Nucleic Acid Synthesis Inhibitors

Phase 3

4962

21

Antineoplastic Agents, Alkylating

Phase 3

4603

22

topoisomerase I inhibitors

Phase 3

1370

23

Doxorubicin

approved, investigational

Phase 1, Phase 2

1751

23214-92-8

31703

Synonyms:

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

111266-55-8

14-Hydroxydaunomycin

14-Hydroxydaunorubicine

14-hydroxydaunomycin

14-hydroxydaunorubicine

23214-92-8

23257-17-2

24385-08-8

25311-50-6

25316-40-9

25316-40-9 (hydrochloride)

29042-30-6

AC1L1M5T

AC1Q29OJ

ADM

ADR

Adriablastin

Adriacin (hydrochloride salt)

Adriamycin

Adriamycin PFS

Adriamycin PFS (hydrochloride salt)

Adriamycin RDF

Adriamycin RDF (hydrochloride salt)

Adriamycin Semiquinone

Adriamycin semiquinone

Adriblas tina

Adriblastin

Adriblastina

Adriblastina (TN)

Adriblastina (hydrochloride salt)

Aerosolized Doxorubicin

BPBio1_000502

BRD-K92093830-003-04-3

BSPBio_000456

BSPBio_001031

C01661

C27H29NO11

CCRIS 739

CHEBI:28748

CHEMBL179

CID31703

Caelyx

Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74

Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120

D03899

DB00997

DM2

DOX-SL

Doxil

Doxo

Doxorubicin

Doxorubicin (USAN/INN)

Doxorubicin HCl

Doxorubicin Hydrochloride

Doxorubicin [USAN:INN:BAN]

Doxorubicin citrate

Doxorubicin hydrochloride (hydrochloride salt)

Doxorubicin-P4/D10

Doxorubicin-P4/D10 conjugate

Doxorubicin-hLL1

Doxorubicin-hLL1 conjugate

Doxorubicina

Doxorubicina [INN-Spanish]

Doxorubicine

Doxorubicine [INN-French]

Doxorubicinum

Doxorubicinum [INN-Latin]

EINECS 245-495-6

FI 106

Farmablastina (hydrochloride salt)

HMS2089H06

HSDB 3070

Hydroxydaunomycin hydrochlor ide (hydrochloride salt)

Hydroxydaunomycin hydrochloride (hydrochloride salt)

Hydroxydaunorubicin

Hydroxydaunorubicin hydrochloride (hydrochloride salt)

JT9100000

LMPK13050001

LS-1029

LS-165655

MLS000759533

Myocet

NCI-C01514

NChemBio.2007.10-comp13

NDC 38242-874

NIOSH/JT9100000

NSC 123127

Prestwick0_000438

Prestwick1_000438

Prestwick2_000438

Prestwick3_000438

Probes1_000151

Probes2_000129

RDF Rubex

Resmycin

Rubex

Rubex (hydrochloride salt)

SMP1_000106

SPBio_002395

TLC D-99

ThermoDox

Triferric doxorubicin

UNII-80168379AG

adiblastine (hydrochloride salt)

adr iablatina (hydrochloride salt)

adriablastine (hydrochloride salt)

adriablatina (hydrochloride salt)

adriblatina (hydrochloride salt)

doxorubicin

nchembio809-comp5

24

Paclitaxel

approved, vet_approved

Phase 1, Phase 2

2864

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

157069-30-2

33069-62-4

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.

7-Epi-Paclitaxel

7-Epi-Taxol

7-Epipaclitaxel

7-Epitaxol

7-epi-Paclitaxel

7-epi-Taxol

AB00513812

ABI 007

ABI-007

ABI007

AC-675

AC1L1IOG

AC1L1VJI

AC1L9AVF

ACon1_002231

ANX-513

Abraxane

Abraxane (TN)

Abraxane I.V. Suspension

Abraxis BioScience brand of albumin-bound paclitaxel

Ambotz33069-62-4

Anzatax

Asotax

BIDD:PXR0046

BMS 181339-01

BMS-181339

BMS-181339-01

BPBio1_000320

BRD-A23723433-001-01-2

BRD-A28746609-001-04-0

BRD-K62008436-001-03-1

BSPBio_000290

BSPBio_001152

BSPBio_002614

Bio-0076

Bio1_000362

Bio1_000851

Bio1_001340

Bio2_000416

Bio2_000896

Bristaxol

C07394

C466458

C47H51NO14

CCRIS 8143

CHEBI:103439

CHEBI:45863

CHEMBL100910

CHEMBL418410

CHEMBL48

CID36314

CID441276

CID4666

CID6713921

CID6915727

CPD-8718

Capxol

D00491

DB01229

DHP-107

DHP-208

DRG-0190

DTS-301

DivK1c_000441

EU-0101201

Ebetaxel

EmPAC

Epitaxol

Genaxol

Genetaxyl

Genexol

Genexol-PM

HMS1362J13

HMS1568O12

HMS1792J13

HMS1922K08

HMS1990J13

HMS2090D07

HMS2093K15

HMS501G03

HSDB 6839

I06-0014

IDI1_000441

IDI1_002171

Intaxel

KBio1_000441

KBio2_000492

KBio2_002016

KBio2_002509

KBio2_003060

KBio2_004584

KBio2_005077

KBio2_005628

KBio2_007152

KBio2_007645

KBio3_000903

KBio3_000904

KBio3_001834

KBio3_002987

KBioGR_000492

KBioGR_001893

KBioGR_002509

KBioSS_000492

KBioSS_002016

KBioSS_002517

LMPR0104390001

LS-31070

LipoPac

Lopac0_001201

MBT 0206

MEGxp0_001940

MLS000863266

MLS001077297

MLS002154218

MLS002172439

MLS002695976

MPI-5018

Micellar Paclitaxel

Mitotax

MolPort-001-742-627

MolPort-003-665-783

MolPort-003-932-365

NCGC00024995-02

NCGC00024995-03

NCGC00024995-04

NCGC00024995-05

NCGC00024995-06

NCGC00024995-07

NCGC00164367-01

NCGC00164367-02

NCGC00164367-03

NCI60_000601

NINDS_000441

NK 105

NP-010981

NSC 125973

NSC-125973

NSC125973

NSC358882

Nanotaxel

Neuro_000060

Nova-12005

OAS-PAC-100

OncoGel

Onxal

Onxol

Onxol, Taxol, Nov-Onxol, Paclitaxel

P1632

Paclical

Pacligel

Paclitaxel

Paclitaxel (JAN/USP)

Paclitaxel (JAN/USP/INN)

Paclitaxel (Taxol)

Paclitaxel [USAN:INN:BAN]

Paxceed

Paxene

Paxoral

Plaxicel

Praxel

Prestwick0_000155

Prestwick1_000155

Prestwick2_000155

Prestwick3_000155

Probes2_000350

QW 8184

S-8184 Paclitaxel Injectable Emulsion

S1150_Selleck

SDCCGMLS-0066823.P001

SDP-013

SMP1_000228

SMR000394086

SMR000857385

SPBio_000943

SPBio_002229

SPECTRUM1503908

ST50306996

Spectrum2_000872

Spectrum3_001057

Spectrum4_001197

Spectrum5_001491

Spectrum_001536

T 7402

T1912_SIGMA

T7191_SIGMA

T7402_SIGMA

TA1

TAXOL (TN)

TAXOL, 10-EPI,

TXL

TaxAlbin

Taxol

Taxol A

Taxol Konzentrat

Taxol.RTM. (Registered Trademark)

UNII-P88XT4IS4D

UPCMLD-DP108:001

UPCMLD-DP108:002

Vascular Wrap

Xorane

Yewtaxan

abi-007

albumin-bound paclitaxel

cMAP_000068

nab-paclitaxel

nchembio.188-comp1

nchembio.2007.34-comp9

nchembio.215-comp9

nchembio853-comp6

paclitaxel

weekly paclitaxel

25

Doxil

Approved June 1999

Phase 1, Phase 2

1751

31703

Synonyms:

Dox-SL

Doxil

Evacet

LipoDox

Pegylated Liposomal Doxorubicin Hydrochloride

liposomal doxorubicin

26

taxane

Phase 1, Phase 2

354

27

Albumin-Bound Paclitaxel

Phase 1, Phase 2

2864

Interventional clinical trials:

id	Name	Status	NCT ID	Phase
1	Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma	Active, not recruiting	NCT00075582	Phase 3
2	Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma	Suspended	NCT02567435	Phase 3
3	Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma	Completed	NCT00949325	Phase 1, Phase 2
4	To Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors	Recruiting	NCT01962103	Phase 1, Phase 2

Search NIH Clinical Center for Spindle Cell Rhabdomyosarcoma

Genetic Tests for Spindle Cell Rhabdomyosarcoma

Anatomical Context for Spindle Cell Rhabdomyosarcoma

Sources:
³⁶MalaCards
See all MalaCards sources

MalaCards organs/tissues related to Spindle Cell Rhabdomyosarcoma:

³⁶

Tongue, Prostate

Publications for Spindle Cell Rhabdomyosarcoma

Sources:
⁵⁷PubMed
See all MalaCards sources

Articles related to Spindle Cell Rhabdomyosarcoma:

(show all 31)

id	Title	Authors	Year
1	Spindle-cell rhabdomyosarcoma of the thumb: Rare site, rare tumor in a child. (27502215)	Mahana S.... Gupta R.	2016
2	Paratesticular Spindle Cell Rhabdomyosarcoma. (26500726)	Dey B.... Chander J.	2015
3	Spindle cell rhabdomyosarcoma of the retroperitoneum: an unusual case developed in a pregnant woman but obscured by pregnancy. (25197361)	Yu L.... Yang S.J.	2014
4	Spindle cell rhabdomyosarcoma in the hypopharynx of an adult. (25197406)	Wu T.T.... Zheng Z.J.	2014
5	An Adult Case of Paratesticular Spindle Cell Rhabdomyosarcoma. (26839788)	Delto J.C.... Nieder A.M.	2014
6	An adult spindle cell rhabdomyosarcoma in the head and neck region with long-term survival: a case report. (24946859)	Hartmann S.... MA1ller-Richter U.D.	2014
7	Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma. (24272621)	Szuhai K.... Hogendoorn P.C.	2014
8	Recurrent MYOD1 mutations in pediatric and adult sclerosing and spindle cell rhabdomyosarcomas: evidence for a common pathogenesis. (24824843)	Agaram N.P.... Antonescu C.R.	2014
9	Spindle cell rhabdomyosarcoma displaying CD34 positivity: a potential diagnostic pitfall; report of two pediatric cases. (24022313)	KaAsar A.... DervA+A9oA9lu S.	2013
10	Spindle cell rhabdomyosarcoma: a brief diagnostic review and differential diagnosis. (23899074)	Carroll S.J.... Nodit L.	2013
11	Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. (23463663)	Mosquera J.M.... Antonescu C.R.	2013
12	Spindle cell rhabdomyosarcoma of the neck with t(6;8) translocation: report of a case and literature review. (23113671)	Mentrikoski M.J.... LeGallo R.	2013
13	Spindle cell rhabdomyosarcoma of the prostate. (23320845)	Latz S.... Fechner G.	2013
14	Exfoliative cytologic findings of maxillary sinus spindle cell rhabdomyosarcoma. (20518428)	Daneshbod Y.... Khademi B.	2010
15	Aggressive spindle cell rhabdomyosarcoma in an 11-month-old boxer dog. (20460837)	da Roza M.R.... Miguel M.C.	2010
16	Sclerosing spindle cell rhabdomyosarcoma in an adult: report of a new case and review of the literature. (19017660)	Gavino A.C.... Peng Y.	2010
17	Unique case of giant adult paratesticular spindle cell rhabdomyosarcoma. (19036416)	Silvestris N.... Colucci G.	2009
18	Radiation-induced mandibular adult spindle cell rhabdomyosarcoma. (18023143)	Goosens V.... Casselman J.	2008
19	Clinicopathologic analysis of spindle cell rhabdomyosarcoma: report of 8 cases]. (18646700)	Zhang H.T.... Su Q.	2008
20	Kit expression in spindle cell rhabdomyosarcoma can possibly create a different approach for its tumorigenesis and therapy. (16860492)	Diniz G.... Vergin C.	2006
21	Spindle cell rhabdomyosarcoma in adults: clinicopathological and immunohistochemical analysis of seven new cases. (17013628)	Mentzel T.... Kuhnen C.	2006
22	Spindle cell rhabdomyosarcoma in adults. (16006807)	Nascimento A.F.... Fletcher C.D.	2005
23	Paratesticular spindle cell rhabdomyosarcoma diagnosed by fine needle aspiration cytology: a case report. (15966299)	Daneshbod Y.... Rastegar M.	2005
24	Spindle cell rhabdomyosarcoma of the tongue in an infant: a case report with emphasis on differential diagnosis of childhood spindle cell lesions. (15462501)	Gupta A.... Chou P.M.	2004
25	Spindle-cell rhabdomyosarcoma with 2q36 approximately q37 involvement. (12550761)	Debiec-Rychter M.... Sciot R.	2003
26	Paratesticular spindle cell rhabdomyosarcoma in an adult. (11458081)	Kizer W.S.... Schwartz B.F.	2001
27	Spindle cell rhabdomyosarcoma in adults. A case report and literature review. (10674275)	Fernando Val-Bernal J.... GA^mez-RomA!n J.J.	2000
28	Cytogenetic study of a spindle-cell rhabdomyosarcoma of the parotid gland. (10087951)	Gil-Benso R.... Llombart-Bosch A.	1999
29	Spindle cell rhabdomyosarcoma (so-called) in adults: report of two cases with emphasis on differential diagnosis. (9537474)	Rubin B.P.... Fletcher C.D.	1998
30	Spindle cell rhabdomyosarcoma: histologic variant of embryonal rhabdomyosarcoma with association to favorable prognosis. (7882713)	Leuschner I.	1995
31	Spindle cell rhabdomyosarcoma. A prognostically favorable variant of rhabdomyosarcoma. (1599014)	Cavazzana A.O.... Salviati G.	1992

Genes related to Spindle Cell Rhabdomyosarcoma

Sources:
⁸Cosmic, ¹³DISEASES, ²¹GeneCards
See all MalaCards sources

Genes related to Spindle Cell Rhabdomyosarcoma:

- Elite gene

- Cancer Census gene in COSMIC

id	Symbol	Description	Score	Implication
1	MYOD1	Myogenic Differentiation 1	35.65	DISEASES inferred ¹³ GeneCards inferred via : Disorders, Publications (show sections)
2	MB	Myoglobin	33.84	DISEASES inferred ¹³ GeneCards inferred via : Disorders, Publications (show sections)
3	DES	Desmin	28.41	GeneCards inferred via : Disorders, Publications (show sections)
4	MUC1	Mucin 1, Cell Surface Associated	27.92	GeneCards inferred via : Disorders, Publications (show sections)
5	GFAP	Glial Fibrillary Acidic Protein	27.92	GeneCards inferred via : Disorders, Publications (show sections)
6	S100B	S100 Calcium Binding Protein B	27.92	GeneCards inferred via : Disorders, Publications (show sections)

Variations for Spindle Cell Rhabdomyosarcoma

Sources:
⁸Cosmic
See all MalaCards sources

Cosmic variations for Spindle Cell Rhabdomyosarcoma:

⁸ (show all 41)

id	Cosmic Mut ID	Gene Symbol	COSMIC Disease Classification (Primary site, Site subtype, Primary histology, Histology subtype)	Mutation CDS	Mutation AA	Conf
1	COSM1745010	MYOD1	soft tissue,NS,rhabdomyosarcoma,spindle cell	c.365T>G	p.L122R	7
2	COSM585	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.183A>T	p.Q61H	5
3	COSM584	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.182A>G	p.Q61R	5
4	COSM13016	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.226G>C	p.E76Q	5
5	COSM564	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>A	p.G12D	5
6	COSM580	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.181C>A	p.Q61K	5
7	COSM13014	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.214G>A	p.A72T	5
8	COSM14271	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1508G>T	p.G503V	5
9	COSM483	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>T	p.G12V	5
10	COSM1651691	ALK	soft tissue,NS,rhabdomyosarcoma,embryonal	c.3830T>C	p.I1277T	5
11	COSM521	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>A	p.G12D	5
12	COSM480	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>A	p.G12S	5
13	COSM11081	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.733G>T	p.G245C	5
14	COSM45255	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.668C>G	p.P223R	5
15	COSM496	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.181C>A	p.Q61K	5
16	COSM775	PIK3CA	soft tissue,NS,rhabdomyosarcoma,embryonal	c.3140A>G	p.H1047R	5
17	COSM5664	CTNNB1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.121A>G	p.T41A	5
18	COSM574	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.38G>T	p.G13V	5
19	COSM3744763	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5428G>T	p.D1810Y	5
20	COSM959251	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5113G>A	p.E1705K	5
21	COSM3738459	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5437G>A	p.E1813K	5
22	COSM569	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.37G>C	p.G13R	5
23	COSM516	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>T	p.G12C	5
24	COSM486	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.37G>C	p.G13R	5
25	COSM13013	PTPN11	soft tissue,NS,rhabdomyosarcoma,embryonal	c.205G>A	p.E69K	5
26	COSM553	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.182A>T	p.Q61L	5
27	COSM5692	CTNNB1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.134C>A	p.S45Y	5
28	COSM4169595	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5425G>A	p.G1809R	5
29	COSM532	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.38G>A	p.G13D	5
30	COSM3738549	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5365-1G>T	p.?	5
31	COSM45005	TP53	soft tissue,NS,rhabdomyosarcoma,embryonal	c.739A>G	p.N247D	5
32	COSM481	HRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>T	p.G12C	5
33	COSM562	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>T	p.G12C	5
34	COSM3738451	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.5439G>T	p.E1813D	5
35	COSM763	PIK3CA	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1633G>A	p.E545K	5
36	COSM760	PIK3CA	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1624G>A	p.E542K	5
37	COSM476	BRAF	soft tissue,NS,rhabdomyosarcoma,embryonal	c.1799T>A	p.V600E	5
38	COSM522	KRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.35G>C	p.G12A	5
39	COSM143842	ALK	soft tissue,NS,rhabdomyosarcoma,embryonal	c.3673G>A	p.D1225N	5
40	COSM393242	DICER1	soft tissue,NS,rhabdomyosarcoma,embryonal	c.2062C>T	p.R688*	5
41	COSM563	NRAS	soft tissue,NS,rhabdomyosarcoma,embryonal	c.34G>A	p.G12S	5

Expression for genes affiliated with Spindle Cell Rhabdomyosarcoma

Sources:
¹⁸Gene Expression Omnibus DataSets
See all MalaCards sources

Search GEO for disease gene expression data for Spindle Cell Rhabdomyosarcoma.

Pathways for genes affiliated with Spindle Cell Rhabdomyosarcoma

Sources:
⁵⁵PathCards, ⁵⁹R&D Systems
See all MalaCards sources

Pathways related to Spindle Cell Rhabdomyosarcoma according to GeneCards Suite gene sharing:

id	Super pathways	Score	Top Affiliating Genes
1	Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers⁵⁹	9.5	DES, MYOD1
2	Neural Stem Cell Differentiation Pathways and Lineage-specific Markers⁵⁹	9.1	GFAP, S100B